No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ONTO240816C260000
- 1.50
- +1.05+233.33%
15min DelayClose Jul 23 16:00 ET
1.50High1.42Low
1.42Open0.45Pre Close2 Volume4 Open Interest260.00Strike Price292.00Turnover56.58%IV23.40%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.0953Delta0.0055Gamma163.01Leverage Ratio-0.1097Theta0.0125Rho15.54Eff Leverage0.0923Vega
Intraday
- 5D
- Daily
News
Onto Innovation (ONTO) Advances While Market Declines: Some Information for Investors
Express News | Shares of Companies Within the Broader Technology Sector Are Trading Lower Amid a Selloff in Chips and AI-related Stocks
Onto Innovation Down Over 12%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Stifel Maintains Onto Innovation(ONTO.US) With Buy Rating, Raises Target Price to $270
Analysts Conflicted on These Technology Names: Onto Innovation (ONTO) and Littelfuse (LFUS)
Comments
Onto Innovation's declining ROCE trend is worrisome. Despite increased capital investment, returns and sales are dropping, possibly indicating a loss of competitive edge or market share. Despite poor fundamentals, investors remain hopeful due to significant stock growth in the past three years. However, if these trends persist, the company's long-term performance could suffer.
Returns On Capital Signal Tricky Times Ahead For Onto Innovation (NYSE:ONTO) 1
Onto Innovation Inc.'s high P/E ratio is worrying considering its lower predicted growth compared to the broader market. The current upbeat sentiment towards the company's stock may not last unless there's a substantial boost in its earnings growth.
Insiders selling shares of Onto Innovation Inc. slightly below current price could concern shareholders. Lack of recent insider transactions is neutral. 1.0% insider ownership suggests alignment with other shareholders. Yet, last 12 months' insider transactions are discouraging.
Observers warn falling returns may limit Onto Innovation's future growth even with apparent reinvestment. Despite strong stock performance, they suggest monitoring company earnings to see if investments pay off.
$Adtalem Global Education(ATGE.US$ $Beneficient(BENF.US$ $Ebix Inc(EBIX.US$ $Emergent BioSolutions(EBS.US$ $EnerSys(ENS.US$ $ESGL Holdings(ESGL.US$ $FutureFuel(FF.US$ $IonQ Inc(IONQ.US$ $Maxeon Solar Technologies(MAXN.US$ $MercadoLibre(MELI.US$ $Macrogenics(MGNX.US$ $Novo-Nordisk A/S(NVO.US$ $Onto Innovation(ONTO.US$ $Oracle(ORCL.US$ $Pagaya Technologies(PGY.US$ $Xtant Medical(XTNT.US$
1
Read more